Deal Spotlight
Jul 12, 2026July 12, 2026
Resilience raises €414M Series D with 8VC/Joe Lonsdale
€414M
round size
series-d
stage
The funding round closed on June 24, 2026, with 8VC/Joe Lonsdale participating as the lead investor. The company has raised a total of €616.4M to date across two rounds.
Resilience is a technology-focused biomanufacturing company in the Healthcare & Life Sciences sector. It provides services ranging from cell and gene therapy to vaccines and biologics. The company is based in the United States and is at the series-c-plus stage.
Related insights
- Deal SpotlightAgora Labs raises EUR4.3M Seed round backed by famiglia Mussetto and P101
- Deal SpotlightSpiko raises EUR79.9M Series B backed by NEA
- Deal SpotlightLive2.ai raises EUR14.3M Series A backed by IvyCap Ventures
- Data AnalysisThe First Cheque Is Not an Angel’s: Czech Founders Bootstrap or Take a Grant First
Explore the full dataset
Brouky tracks 37,000+ investors and 122,000+ investments across 134,000+ startups. Search by country, stage, and sector.